Number sleven
8 minutes ago
JRoon, From the perspective of an insurance provider, that is where they should be categorized. From a legal perspective they are providing reimbursement for drugs that are intended to treat CVD. If they provide incentives for Doctors or patients, in this case financial incentive, they are actively